Peripheral Arterial Disease study: Exercise Intervention
Official title Prehabilitation and Rehabilitation in PAD
ClinicalTrials.gov ID: NCT06566976
What this study is testing
- What it's testing
- This study is testing whether exercise therapy before and after artery stenting improves outcomes for people with peripheral arterial disease.
- Who it's for
- You may be able to join if you have peripheral arterial disease and are scheduled for artery stenting.
- What's involved
- You would follow a supervised exercise program before your stent procedure and continue exercising after the procedure. You may have a few check‑ins with the study team.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- Male or Female adult diagnosed with peripheral artery disease (PAD)
- Experiencing leg pain while walking
- Scheduled to have a stent for PAD
- Able to perform exercise safely
- Postmenopausal and not of child bearing capacity
You likely can't join if
- Medically unstable patients
- Recent MI within 3 months
- Malignancy
- Uncontrolled diabetes mellitus (HBA1C ≥8 mmol/l)
- Alcoholism or other recreational drug use
The study team makes the final eligibility decision.
Where it is enrolling
- Palo Alto, California, United States
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part, but confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
This study is enrolling now at Palo Alto, California, United States. Enter your location above to see the nearest enrolling site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool that is independent of the study sponsor. Details come from ClinicalTrials.gov. The study team decides eligibility, and your own doctor gives medical advice.